PL397623A1 - Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie - Google Patents

Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie

Info

Publication number
PL397623A1
PL397623A1 PL397623A PL39762311A PL397623A1 PL 397623 A1 PL397623 A1 PL 397623A1 PL 397623 A PL397623 A PL 397623A PL 39762311 A PL39762311 A PL 39762311A PL 397623 A1 PL397623 A1 PL 397623A1
Authority
PL
Poland
Prior art keywords
learning
preparation
nutritional supplement
pharmaceutical
manufacture
Prior art date
Application number
PL397623A
Other languages
English (en)
Inventor
Bogdan Lang
Andrzej W. Lipkowski
Mariusz Sacharczuk
Elżbieta Salińska
Original Assignee
Napco S. Ar.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napco S. Ar.L. filed Critical Napco S. Ar.L.
Priority to PL397623A priority Critical patent/PL397623A1/pl
Priority to PCT/EP2012/077100 priority patent/WO2013098415A1/en
Priority to EP12818900.8A priority patent/EP2797618A1/en
Priority to US14/369,246 priority patent/US20150018282A1/en
Publication of PL397623A1 publication Critical patent/PL397623A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/06Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)

Abstract

Ujawniono preparat poprawiajacy pamiec oraz uczenie sie, który zawiera enzymatyczny hydrolizat bialek zwierzecej tkanki ukladu nerwowego. Wspomniana tkanke stanowi rdzen kregowy zwierzat rzeznych, zas bialkiem jest bialko mielinowe. Wynalazek dotyczy równiez sposobu wytwarzania preparatu poprawiajacego pamiec oraz uczenie sie i produktu leczniczego a takze dodatku zywieniowego zawierajacego wymieniony enzymatyczny hydrolizat bialek. Ponadto przedmiotem wynalazku jest zastosowanie hydrolizatu bialek zwierzecej tkanki ukladu nerwowego.
PL397623A 2011-12-30 2011-12-30 Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie PL397623A1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL397623A PL397623A1 (pl) 2011-12-30 2011-12-30 Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie
PCT/EP2012/077100 WO2013098415A1 (en) 2011-12-30 2012-12-29 Preparation for improving memory and learning and use thereof
EP12818900.8A EP2797618A1 (en) 2011-12-30 2012-12-29 Preparation for improving memory and learning and use thereof
US14/369,246 US20150018282A1 (en) 2011-12-30 2012-12-29 Preparation for improving memory and learning and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL397623A PL397623A1 (pl) 2011-12-30 2011-12-30 Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie

Publications (1)

Publication Number Publication Date
PL397623A1 true PL397623A1 (pl) 2013-07-08

Family

ID=47605455

Family Applications (1)

Application Number Title Priority Date Filing Date
PL397623A PL397623A1 (pl) 2011-12-30 2011-12-30 Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie

Country Status (4)

Country Link
US (1) US20150018282A1 (pl)
EP (1) EP2797618A1 (pl)
PL (1) PL397623A1 (pl)
WO (1) WO2013098415A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3397078A1 (en) 2015-12-28 2018-11-07 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
JP7466886B2 (ja) * 2019-06-21 2024-04-15 学校法人帝京大学 孵化後の鳥類ヒナの学習特性を利用した認知機能向上薬のスクリーニング方法
CN116172205A (zh) * 2022-11-18 2023-05-30 黑龙江飞鹤乳业有限公司 碱性蛋白的用途,包括其的营养组合物、食品及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001253701A1 (en) 2000-04-20 2001-11-07 Todd C. Sacktor A memory enhancing protein
CN102784385B (zh) * 2000-08-21 2015-11-25 阿皮托普技术(布里斯托尔)有限公司 肽选择方法
US7912553B2 (en) 2002-11-27 2011-03-22 Jun-ichi Nishizawa Electromagnetic wave applicator
WO2006019804A2 (en) * 2004-07-14 2006-02-23 Wyeth Compositions and methods of purifying myelin-associated glycoprotein (mag)
EP1960425A2 (en) * 2005-11-07 2008-08-27 Copenhagen University Neurotrophin-derived peptide sequences
US20100081613A1 (en) 2006-10-11 2010-04-01 The Trustees Of Columbia University In The City Of New York Methods and compositions for enhancing memory
US20100093646A1 (en) 2006-10-23 2010-04-15 Kyowa Hakko Bio Co., Ltd. Method for enhancing memory in normal individual
KR101063330B1 (ko) 2008-10-14 2011-09-07 서울대학교산학협력단 단백질을 유효성분으로 함유하는 기억력 증진용 약학 조성물
US20120266263A1 (en) 2009-10-14 2012-10-18 Mount Sinai School Of Medicine Method of treating memory disorders and enhancing memory using igf-ii compounds

Also Published As

Publication number Publication date
EP2797618A1 (en) 2014-11-05
US20150018282A1 (en) 2015-01-15
WO2013098415A1 (en) 2013-07-04

Similar Documents

Publication Publication Date Title
MY182593A (en) Composition containing chitin and digestible proteins
MY180626A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
EA201300669A1 (ru) Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение
CL2015001159A1 (es) Hidrolizado de colágeno producido por hidrólisis enzimática de gelatina de hueso tipo b; complemento nutricional que lo comprende; y método de producción.
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
MX2015012515A (es) Sistemas y métodos para el diseño y fabricación de calzado de protección de pacientes.
MX2019005300A (es) Polimeros enlazados al proton para administracion oral.
MX2021000388A (es) Suplemento alimenticio.
BR112015024757A2 (pt) métodos para aprimorar síntese de proteína muscular seguindo treinamento simultâneo
NI201400069A (es) Proceso para aislamiento de una composición de proteína y una composición de grasa a partir de aves de corral deshuesadas mecánicamente.
BR112014007741A2 (pt) bebidas nutritivas
EA023877B9 (ru) Макет головы для медицинской подготовки хирургов и способ
BR112015001227A2 (pt) métodos de produção de hidrolisato de queratina, de degradação de queratina e de produção de ração animal, usos de uma composição e de hidrolisato de queratina, hidrolisato de queratina, composição de aditivo alimentar, alimento e produto.
PH12018500992A1 (en) Nutritional compositions comprising a casein hydrolysate, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate
BR112013026447A2 (pt) métodos para a regulação da expressão de gene de sirtuína
MX2017000014A (es) Metodo para producir acido graso de cadena media con el uso de beta-cetoacil-proteina portadora de acilo (acp) sintasa.
TW201613631A (en) Ghrelin secretion promoter
PL397623A1 (pl) Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie
CL2013001841A1 (es) Reactor de membrana para la fabricacion de hidrolizados de proteina vegetal; metodo para la fabricacion de hidrolizados de proteina vegetal; e hidrolizado de proteina vegetal.
EA201390867A1 (ru) Композиции на основе глины и обножки, способ их получения и их применение в питании и терапевтическом лечении
EA201270176A1 (ru) Производные тазаротена
EA201391742A1 (ru) Фармацевтическая композиция, включающая фексофенадин
NI201300115A (es) Producto de proteínas y proceso para la fabricación de un producto de proteínas a partir de exudado de carne cruda.
BR112015011152A2 (pt) Planta geneticamente modificada, construção genética e método de processamento agrícola ou preparação de alimentação para animais
BR112017025481A2 (pt) hidrolisado de proteína e uso do mesmo, ração animal ou suplemento de animal de estimação ou produto farmacêutico de animal de estimação tendo palatabilidade melhorada, método de preparação de uma ração animal, e, método para aumentar a palatabilidade de uma composição para consumo.